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Corrected Qt interval in patients with metabolic syndrome
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ÖZET
Amaç: Metabolik sendrom artmış kardiyovasküler morta-
lite ve morbidite ile ilişkili olabilir. Fakat metabolik send-
romun  QT  sürelerinin  uzamasına  neden  olduğu  halen 
belirsizdir. Bu çalışmanın amacı metabolik sendromla bir-
likte bulunan uzamış QT süresinin sıklığını araştırmak ve 
varsa aralarındaki ilişkiyi göstermektir. Bu amaçla geniş 
bir hasta grubunda metabolik sendromun QT uzaması ile 
ilişkisini araştırmayı amaçladık.
Gereç ve yöntem: Çalışmaya 1009 hasta dahil edildi. 
Metabolik sendrom IDF kriterlerine göre tanımlandı ve QT 
süresi Bazett formülü kullanılarak hesaplandı. QT≤0,44 
sn normal olarak kabul edildi.
Bulgular: Çalışmaya alınan 1009 olgunun 278’i erkek, 
731’i kadındı. Erkeklerin Bazett formülüne göre düzeltil-
miş ortalama QT sureleri 0,448±0,040 sn, kadınların ise 
0,449±0 ,050 sn idi. Hem erkek hem de kadın hastalar-
da QTc suresi normale göre anlamlı yüksek bulundu (p< 
0,01).
Sonuç: Metabolik sendrom uzamış QT süresiyle ilişkili 
bulundu. Çalışmamızda elde ettiğimiz bulgular metabolik 
sendrom hastalarında QT süresinin artmış olduğunu des-
teklemektedir.
Anahtar kelimeler: Metabolik kardiyovasküler sendrom, 
aritmi, kalp ve damar hastalıkları, QT süresi
ABSTRACT
Objectives:  Metabolic  syndrome  may  be  associated 
with  increased  cardiovascular  mortality  and  morbidity. 
However, prolongation of QT intervals due to metabolic 
syndrome is still unclear. The purpose of this study was 
to investigate the incidence prolonged QT intervals in pa-
tients with metabolic syndrome and also demonstrate the 
relationship between them. Therefore, we aimed to inves-
tigate the relationship between metabolic syndrome and 
the QT prolongation in a large patient group.
Materials and methods: A total of 1009 individuals were 
enrolled in this study. Metabolic syndrome was defined 
according to the IDF criteria and the QTc intervals were 
measured by using Bazett Formula. QT ≤ 0.44 second 
was accepted as normal.
Results: Totally, 278 male and 731 female individuals of 
1009 cases were enrolled in this study. The average dura-
tion of corrected QT of men according to the Bazzett for-
mula were found as 0,448±0,04 second and QT interval 
of women were 0,449±0,05 second. QT intervals of both 
women and men with metabolic syndrome were signifi-
cantly higher than normal limits of QT interval (p<0,01).
Conclusion:  Metabolic  syndrome  found  as  associated 
with a prolonged QTc. Results of our study suggest that 
QTc interval length was increased in patients with meta-
bolic syndrome.
Key words: Metabolic cardiovascular syndrome, arrhyth-
mia, cardiovascular diseases, QT interval
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INTRODUCTION
The QT interval reflects the duration of ventricular 
myocardial repolarization and depolarization, and is 
highly dependent on heart rate. QT interval is short-
er at a faster heart rate, and longer at a slower heart 
rate. A prolonged QT interval has been found to be 
associated with electrical instability of myocardium 
and leads to adverse cardiovascular outcomes, in-
cluding ventricular fibrillation and sudden death.1,3 
Prolongation  of  corrected  QT  (QTc)  can  also  be 
used to predict cardiac death in patients after myo-
cardial infarction, in patients with diabetes, or heart 
failure. 4,7 The prolongation of QT interval has been 
reported to be associated with cardiovascular mor-
bidity and mortality in apparently healthy adults. 2,8
Recent  studies  indicate  a  high  prevalence  of 
increased QTc interval length in patients affected 
by the metabolic syndrome (MetS). The purpose of 
the present study was to identify the prevalence of 
MetS along with a prolonged QTc interval, and to 
determine  whether  an  association  exists  between 
prolonged QTc and MetS. To clarify the relation-
ship between QTc and MetS, a large population was 
employed in this study, and the relationship was dis-
cussed.
MATERIALS AND METHODS
Totally 1009 patient, 278 male (27.55%) and 731 
female  (72.45%)  with  MetS  were  retrospectively 
studied in Hypertension Clinic of Şişli Etfal Edu-
cation and Research Hospital. Metabolic syndrome 
was determined according to the IDF guidelines. 
Patients treated with antihypertensive, antidiabetes, 
and antidyslipidemia agents or taking any medica-
tion known to affect QT intervals were excluded 
from the study. The exclusion was also extended 
to subjects with histories of coronary heart disease, 
valvular heart disease, stroke, hepatic, renal, thy-
roid diseases, and arrhythmia including atrial flutter, 
atrial fibrillation, and third-degree atrioventricular 
block or with a cardiacpacemaker.
Electrocardiograms  were  collected  from  the 
patients. QT and R-R intervals was averaged over 3 
consecutive cycles on lead V2 or V3 using a gradu-
ated lens as QT in the anteroseptal leads provides 
the closest approximation to the maximum QT.  9 
In accordance with the latest recommendations for 
clinical QT interval measurement.  10 QT intervals 
were measured from the beginning of the QRS com-
plex to the visual return of the T-wave to the isoelec-
tric line. Corrected QT interval was calculated using 
the Bazett formula (QTc = QT/√RR) and QT ≤0,440 
sn was accepted normal.
The  data  were  analyzed  using  SPSS  version 
13.0 for Windows (SPSS Inc. Chicago, Illinois). A 
Student t test was used for the comparison of con-
tinuous variables. Analyses were also conducted to 
determine whether there was an association between 
a prolonged QTc interval and metabolic syndrome. 
A p value of <0,05 was considered significant.
RESULTS
The  study  included  278  (27.55%)  male  and  731 
(72.45%) female individuals of a total of 1009 cas-
es. The mean ages of men were 55.91±10.70 years 
and that of women was 55.09±9.65 years. The aver-
age duration of QTc of men according to the Ba-
zzett formula were determined 0.448±0.04 second 
and QT interval of women were 0.449±0.05 second. 
49.25% of all men and 50.34% of all women’s QT 
interval were ≥0.44 sn (Table 1). QT interval of both 
women and men were significantly higher than ac-
cepted normal values of QT interval (p< 0,01). Data 
belonging to all study group is presented in Table 
1.
Table 1.The data of all metabolic syndrome patients
Male (n=278) Female (n=731)
Age (year) 55,91±10,70 55,09±9,65
Waist circumference (cm) 101,18±6,35 103,47±8,56
Systolic blood pressure (mm Hg) 154,35±42,21 157,13±21,38
Diastolic blood pressure (mm Hg) 91,16±8,18 93,22±13,28
Glucose level (mg/dl) 114,20±42,20 118,84±51,76
Triglyceride level (mg/dl) 205,16±55,46 197,32±61,37
HDL level (mg/dl) 37,22±6,22 41,54±7,27
QTc interval 0,448±0,04 0,449±0,05
DISCUSSION
The MetS is highly prevalent and associated with 
increased risk for cardiovascular disease and stroke. 
11,14 In 2002, The National Cholesterol Education 
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gorized the MetS as a constellation of hypertension, 
hyperglycemia, dyslipidemia, and increased waist 
circumference as a measure of visceral adiposity.11 
Recently,  the  International  Diabetes  Federation 
(IDF) redefined the MetS.  15 Their new definition 
varies from that of the ATP III in two fundamen-
tal ways. First, the IDF has adopted cutoff points to 
define elevated waist circumference that are lower 
than the traditional ATP III waist circumference cut-
off points for women. Second, the IDF has made 
central obesity a requirement in their definition of 
the MetS, mandating that a person meet the waist 
circumference criterion and also two of the other 
four traditional criteria (increased triglycerides, low 
high density lipoprotein cholesterol, elevated blood 
pressure, or elevated fasting glucose). In our study 
MetS was determined according to the IDF guide-
lines
The QTc interval represents the time from on-
set of depolarization to completion of repolarization 
of the heart, adjusted for heart rate. Prolonged QTc 
interval is an indicator of increased risk for cardiac 
arrhythmia and sudden death. 16 Although a QTc in-
terval of at least 500 ms generally has been shown 
to be associated with a higher risk of torsades de 
pointes,  there  is  no  established  threshold  below 
which prolongation of the QTc interval is considered 
free of proarrhythmic risk. 17,19 Individuals with pro-
longed QTc interval have higher risk for cardiovas-
cular mortality. 16,20-23 Factors that predispose to QTc 
prolongation and higher risk of torsades de pointes 
include older age, female sex, low left ventricular 
ejection fraction, left ventricular hypertrophy, isch-
emia,  bradycardia,  and  electrolyte  abnormalities 
such as hypokalemia and hypomagnesemia. 19 The 
QTc interval has also been related to components of 
the insulin resistance syndrome including increased 
body  mass  index,  upper  body  obesity,  increased 
blood pressure, and increased fasting insulin during 
an oral glucose tolerance test. 24-26
An association between QTc interval and the 
cardiometabolic syndrome has recently been report-
ed by four separate studies. 27-30 In this study, the MS 
was correlated with increasing QTc interval length. 
This is one of the rare study showing a correlation 
between MS and QTc interval length. The results 
showed a marked increase in QTc interval with MS. 
The present study provides evidence that QTc is as-
sociated with MetS and showed that patients with 
MetS had a significantly longer QTcs.
In conclusion, MetS is a risk factor for pro-
longed  QTc  interval,  which  may  further  increase 
cardiovascular morbidity and mortality in the sub-
jects with metabolic syndrome. It is well-known that 
increased QTc has a detrimental effect on cardio-
vascular outcomes, so prolongation of QTc might 
be an early marker for predicting the development 
of cardiovascular disease and a risk factor for ad-
verse outcome in MetS. Treatment of metabolic pa-
rameter abnormality might improve morbidity and 
mortality by preventing the risk of the prolongation 
of the QTc. However, the results suggest that the 
relationship between QTc intervals and MetS war-
rants further study. Future prospective studies will 
be necessary to address this issue.
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